[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-ukri-bbsrc-bbsrc-stfc-deeptech-catalyst-bio-dtc-bio-2026":3,"similar-ukri-bbsrc-bbsrc-stfc-deeptech-catalyst-bio-dtc-bio-2026":22},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":9,"deadline":10,"deadline_note":11,"duration":9,"trl":9,"relevance":9,"why_relevant":9,"early_career":12,"consortium":13,"first_seen":14,"last_updated":14,"update_note":9,"status":15,"stages":16,"call_frequency":9,"next_call_expected":9,"source_url":7,"created_at":17,"updated_at":18,"eligible_countries":19,"description":21,"seo_summary":9},"ukri-bbsrc-bbsrc-stfc-deeptech-catalyst-bio-dtc-bio-2026","BBSRC-STFC DeepTech Catalyst Bio (DTC Bio) 2026","UKRI (BBSRC","https:\u002F\u002Fwww.ukri.org\u002Fopportunity\u002Fbbsrc-stfc-deeptech-catalyst-bio-2026\u002F","£60,000 (£50k R&D funding + £10k innovation voucher)",null,"Sun Aug 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)","EOI deadline 23:59 on 16 August 2026 (final tranche); earlier tranches: 26 June and 17 July 2026. Full application deadline 14 September 2026.",false,"No","Wed May 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)","open","2-stage: Expression of Interest (EOI) → Full application by 14 September 2026; in-person evaluation board 20–22 October 2026","Wed May 20 2026 00:54:03 GMT+0000 (Coordinated Universal Time)","Wed May 20 2026 05:40:03 GMT+0000 (Coordinated Universal Time)",[20],"GB","Open to UK-registered companies under 5 years old, majority founder\u002Femployee-owned, with prior BBSRC\u002FUKRI grant or commercialisation support. Technology must be biological in nature or interact with a biological entity\u002Fprocess. Medical\u002Fclinical devices and therapeutics developed solely for a specific clinical end-point (including diagnostics) are excluded. Provides R&D funding, innovation voucher, business support, and access to UKRI campuses.",{"grants":23},[]]